V.A. Miller
Impact in
- Oncology top 1%
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
-
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 53
- Lung Cancer Research Studies 20
- Colorectal Cancer Treatments and Studies 10
- HER2/EGFR in Cancer Research 8
- Cancer Immunotherapy and Biomarkers 7
- Cancer Treatment and Pharmacology 5
-
- Lung Cancer Treatments and Mutations 41
- Lung Cancer Diagnosis and Treatment 15
- Co-authors
- Mark G. Kris (27 shared papers)Maureen F. Zakowski (6 shared papers)Francis M. Sirotnak (3 shared papers)Howard I. Scher (2 shared papers)Siraj M. Ali (16 shared papers)M. Rossi (1 shared paper)Arabinda K. Das (1 shared paper)Jeffrey S. Ross (21 shared papers)
- Journals
- Annals of Oncology (29 papers)Journal of Clinical Oncology (22 papers)Lung Cancer (6 papers)Journal of Thoracic Oncology (3 papers)Gynecologic Oncology (3 papers)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
V.A. Miller
81 papers receiving 2.9k citations
V.A. Miller's Hit Papers
Peers
Comparison fields: 5 of 85
- Oncology 2.1k
- Pulmonary and Respiratory Medicine 1.6k
- Cancer Research 508
- Otorhinolaryngology 99
- Pathology and Forensic Medicine 350
Countries citing papers authored by V.A. Miller
This map shows the geographic impact of V.A. Miller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by V.A. Miller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites V.A. Miller more than expected).
Fields of papers citing papers by V.A. Miller
This network shows the impact of papers produced by V.A. Miller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by V.A. Miller. The network helps show where V.A. Miller may publish in the future.
Co-authors
The 25 scholars most cited alongside V.A. Miller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 83 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by coadministration of ZD1839 (Iressa), an inhibitor of EGFR tyrosine kinase. Hit paper breakdown → | 2000 | 665 |
| 2 | Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer Hit paper breakdown → | 2019 | 441 |
| 3 | 2011 | 285 | |
| 4 | 2009 | 169 | |
| 5 | 2015 | 147 | |
| 6 | 2004 | 108 | |
| 7 | 2010 | 90 | |
| 8 | 2017 | 82 | |
| 9 | 2009 | 81 | |
| 10 | 2014 | 78 | |
| 11 | 2013 | 72 | |
| 12 | 2017 | 67 | |
| 13 | 2004 | 62 | |
| 14 | 1989 | 56 | |
| 15 | 2014 | 51 | |
| 16 | 2012 | 46 | |
| 17 | 2014 | 41 | |
| 18 | 2004 | 40 | |
| 19 | 2007 | 33 | |
| 20 | 2009 | 32 |
About V.A. Miller
V.A. Miller is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Pathology and Forensic Medicine, having authored 83 papers that have together received 3.0k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (41 papers), Lung Cancer Research Studies (20 papers), Cancer Genomics and Diagnostics (18 papers), Lung Cancer Diagnosis and Treatment (15 papers), Colorectal Cancer Treatments and Studies (10 papers), HER2/EGFR in Cancer Research (8 papers), Cancer Immunotherapy and Biomarkers (7 papers) and Cancer Treatment and Pharmacology (5 papers). The work is most often cited by research in Oncology (2.1k citations), Pulmonary and Respiratory Medicine (1.6k citations), Cancer Research (508 citations), Otorhinolaryngology (99 citations) and Pathology and Forensic Medicine (350 citations). V.A. Miller has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Mark G. Kris, Maureen F. Zakowski, Francis M. Sirotnak, Howard I. Scher, Siraj M. Ali, M. Rossi, Arabinda K. Das, Jeffrey S. Ross, William Pao and Alexa B. Schrock. Their work appears in journals such as Annals of Oncology, Journal of Clinical Oncology, Lung Cancer, Journal of Thoracic Oncology and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.